Status:

COMPLETED

Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Bipolar I Disorder

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The primary aim of this project is to understand whether it is possible to reduce medical risk factors in adults with bipolar disorder and, in doing so, to improve psychiatric and functional outcomes....

Detailed Description

IRRI is aimed at improving sleep/wake and social rhythm disturbance and achieving modest weight reduction by increasing physical activity and improving nutrition and dietary habits, while at the same ...

Eligibility Criteria

Inclusion

  • Age 18 to 55 years
  • Body mass index (BMI) \>25
  • Meets DSM-IV criteria for lifetime bipolar I disorder
  • Is in remission (with possible sub-threshold symptoms), i.e., as a HRDS-25 \< or equal to 10, YMRS \< or equal to 8, and CGI-BP-S \<3 for two weeks
  • Able to give basic informed consent
  • Current diagnosis or past history of anxiety disorder, eating disorder, or other psychiatric comorbidities will not be exclusion criteria for participation, except those listed in the exclusion criteria below

Exclusion

  • Ultra-rapid cycling (\>8 episodes per year) bipolar I disorder
  • Presence of pervasive developmental disorder, antisocial personality disorder, current substance dependence or abuse, and organic mental disorder
  • Unstable and severe medical illness that requires immediate and intensive medical attention, for instance, a subject with a terminal illness or a subject with severe and unstabilized coronary artery disease; these subjects will be immediately referred to the most appropriate medical and psychiatric treatment. When appropriate, the subjects can be reconsidered for inclusion in the study if/when their medical condition becomes compatible with participation in a protocol-driven research study
  • Unwilling or unable to comply with study requirements (i.e., complete forms, attend scheduled evaluations)
  • Not competent to provide informed consent in the opinion of the investigator
  • Women who are planning to become pregnant, currently pregnant, or breast-feeding

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT00746343

Start Date

September 1 2008

End Date

September 1 2013

Last Update

December 12 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213